304 related articles for article (PubMed ID: 16948799)
1. Relationship between systemic nitric oxide metabolites and cyclic GMP in healthy male volunteers.
Metzger IF; Sertorio JT; Tanus-Santos JE
Acta Physiol (Oxf); 2006 Oct; 188(2):123-7. PubMed ID: 16948799
[TBL] [Abstract][Full Text] [Related]
2. Clinical evidence for lead-induced inhibition of nitric oxide formation.
Barbosa F; Sertorio JT; Gerlach RF; Tanus-Santos JE
Arch Toxicol; 2006 Dec; 80(12):811-6. PubMed ID: 16670857
[TBL] [Abstract][Full Text] [Related]
3. Plasma- and urine concentrations of nitrite/nitrate and cyclic Guanosinemonophosphate in intrauterine growth restricted and preeclamptic pregnancies.
Schiessl B; Strasburger C; Bidlingmaier M; Mylonas I; Jeschke U; Kainer F; Friese K
Arch Gynecol Obstet; 2006 Jun; 274(3):150-4. PubMed ID: 16532320
[TBL] [Abstract][Full Text] [Related]
4. Inverse relationship between markers of nitric oxide formation and plasma matrix metalloproteinase-9 levels in healthy volunteers.
Demacq C; Metzger IF; Gerlach RF; Tanus-Santos JE
Clin Chim Acta; 2008 Aug; 394(1-2):72-6. PubMed ID: 18455513
[TBL] [Abstract][Full Text] [Related]
5. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes.
Metzger IF; Sertório JT; Tanus-Santos JE
Free Radic Biol Med; 2007 Sep; 43(6):987-92. PubMed ID: 17697943
[TBL] [Abstract][Full Text] [Related]
6. Metabolites of the L-arginine-NO pathway in patients with left-to-right shunt.
Gorenflo M; Zheng C; Pöge A; Bettendorf M; Werle E; Fiehn W; Ulmer HE
Clin Lab; 2001; 47(9-10):441-7. PubMed ID: 11596905
[TBL] [Abstract][Full Text] [Related]
7. eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite.
Nagassaki S; Sertório JT; Metzger IF; Bem AF; Rocha JB; Tanus-Santos JE
Free Radic Biol Med; 2006 Oct; 41(7):1044-9. PubMed ID: 16962929
[TBL] [Abstract][Full Text] [Related]
8. Effects of extracorporeal shock wave lithotripsy on plasma levels of nitric oxide and cyclic nucleotides in human subjects.
Park JK; Cui Y; Kim MK; Kim YG; Kim SH; Kim SZ; Cho KW
J Urol; 2002 Jul; 168(1):38-42. PubMed ID: 12050488
[TBL] [Abstract][Full Text] [Related]
9. Impairment of the NO/cGMP pathway in the fasting and postprandial state in type 1 diabetes mellitus.
Farkas K; Jermendy G; Herold M; Ruzicska E; Sasvári M; Somogyi A
Exp Clin Endocrinol Diabetes; 2004 May; 112(5):258-63. PubMed ID: 15146372
[TBL] [Abstract][Full Text] [Related]
10. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
Montoliu C; Kosenko E; Del Olmo JA; Serra MA; Rodrigo JM; Felipo V
Liver Int; 2005 Aug; 25(4):787-95. PubMed ID: 15998430
[TBL] [Abstract][Full Text] [Related]
11. Implication of steady state concentrations of nitrite and nitrate metabolites of nitric oxide in plasma and whole blood in healthy human subjects.
Himeno M; Ishibashi T; Nakano S; Furuya K; Yoshida J; Kigoshi T; Uchida K; Nishio M
Clin Exp Pharmacol Physiol; 2004 Sep; 31(9):591-6. PubMed ID: 15479165
[TBL] [Abstract][Full Text] [Related]
12. The effect of varying continuous propofol infusions on plasma cyclic guanosine 3',5'-monophosphate concentrations in anesthetized children.
Engelhardt T; Chan MK; McCheyne AJ; Karsli C; Luginbuehl I; Bissonnette B
Anesth Analg; 2007 Sep; 105(3):616-9. PubMed ID: 17717213
[TBL] [Abstract][Full Text] [Related]
13. An investigation of nitric oxide metabolites during symptomatic myocardial ischaemia in relation to exercise tolerance test.
Elfatih A; Anderson NR; Mansoor S; Ahmed S; Horton R; Holland M; Gama R
Med Sci Monit; 2003 Dec; 9(12):CR511-4. PubMed ID: 14646972
[TBL] [Abstract][Full Text] [Related]
14. L-arginine does not improve biochemical and hormonal response in trained runners after 4 weeks of supplementation.
Alvares TS; Conte-Junior CA; Silva JT; Paschoalin VM
Nutr Res; 2014 Jan; 34(1):31-9. PubMed ID: 24418244
[TBL] [Abstract][Full Text] [Related]
15. A rapid and simple method for the measurement of nitrite and nitrate in plasma by high performance capillary electrophoresis.
Leone AM; Francis PL; Rhodes P; Moncada S
Biochem Biophys Res Commun; 1994 Apr; 200(2):951-7. PubMed ID: 8179632
[TBL] [Abstract][Full Text] [Related]
16. Regional and whole-body markers of nitric oxide production following hyperemic stimuli.
Allen JD; Cobb FR; Gow AJ
Free Radic Biol Med; 2005 May; 38(9):1164-9. PubMed ID: 15808413
[TBL] [Abstract][Full Text] [Related]
17. Alterations in cyclic GMP levels in preeclampsia may reflect increased B-type natriuretic peptide levels and not impaired nitric oxide activity.
Sandrim VC; Palei AC; Sertório JT; Amaral LM; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2011 Aug; 44(12):1012-4. PubMed ID: 21683071
[TBL] [Abstract][Full Text] [Related]
18. Increased nitric oxide production in eating disorders.
Vannacci A; Ravaldi C; Giannini L; Rotella CM; Masini E; Faravelli C; Ricca V
Neurosci Lett; 2006 May; 399(3):230-3. PubMed ID: 16495002
[TBL] [Abstract][Full Text] [Related]
19. Platelet nitric oxide metabolites in migraine.
Shimomura T; Murakami F; Kotani K; Ikawa S; Kono S
Cephalalgia; 1999 May; 19(4):218-22. PubMed ID: 10376166
[TBL] [Abstract][Full Text] [Related]
20. Effect in vitro of cyclic nucleotides-elevating agents on nitric oxide production by human granulocytes from type 2-diabetic patients.
Nogueira-Machado JA; Lima E Silva FC; Lima E Silva R; Medina LO; Costa DC; Chaves MM
Diabetes Metab; 2002 Feb; 28(1):45-50. PubMed ID: 11938028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]